Skip to main content
. 1999 Jan;12(1):97–111. doi: 10.1128/cmr.12.1.97

TABLE 2.

Concentrations of N-nitrosamines, nitrate, and nitrite in saliva of control and schistosomiasis patientsa

Parameter Concnb in group infected with:
Uninfected control S. mansonic S. haematobiumc
N-Nitrosamine concn (μg/day)
 NDMAd 0.27 ± 0.47 [11/27] 2.9 ± 2.9 [64/65] (P < 0.001) 19.2 ± 21 [79/79] (P < 0.001)
 NPIPd 0.6 [1/27] 0.4 ± 0.3 [40/65] 1.6 ± 2.3 [56/79] (P < 0.001)
 NPYRd 0.7 [1/27] 0.9 ± 0.9 [59/65] 1.3 ± 1.9 [58/79] (P < 0.1]
Nitrate concn in saliva (ppm) 41 ± 52 [27/27] 60 ± 59 [61/64] 52 ± 48 [120/129]
Nitrate concn in urine (mg/day) 139 ± 82 [27/27] 249 ± 12 [65/65] (P < 0.001) 174 ± 176 [77/79] (P < 0.005)
Nitrite concn in saliva (ppm) 8.8 ± 9.0 [27/27] 7.8 ± 9.5 [61/64] 7.5 ± 7.9 [120/129]
Nitrite concn in urine (mg/day) 1.7 ± 0.3 [2/27] 3.2 ± 13 [5/65] 7.9 ± 24 [18/79]
a

Reprinted from reference 161 with permission of the publisher. 

b

Values are mean ± SD of individual samples [number of positive samples/total number assayed]. 

c

Comparison between the control group, S. mansoni-infected patients, and S. haematobium-infected patients by the Wilcoxon rank sum test. 

d

Volatile nitrosamines: NDMA, N-nitrosodimethylamine; NPIP, N-nitrosopiperidine; NPR, N-nitrosopyrrolidine. 

HHS Vulnerability Disclosure